Date |
Report No. |
Title |
Date Oct. 4, 2011 |
Report No. GAO-12-104T |
Title
United States Government Accountability Office GAO
For Release on Delivery Expected at 10:30 a.m. EDT Tuesday, October 4, 2011 Testimony
Before the Subcommittee on Federal Financial Management, Government Information, Federal Services, and International Security, Committee on Homeland Security and Governmental Affairs, U.S. Senate MEDICARE PART D Instances of Questionable Access to Prescription Dr... |
Date Sept. 6, 2011 |
Report No. GAO-11-699 |
Title
United States Government Accountability Office GAO
September 2011 Report to Congressional Requesters MEDICARE PART D Instances of Questionable Access to Prescription Drugs GAO-11-699 September 2011 MEDICARE PART D
Instances of Questionable Access to Prescription Drugs
Highlights of GAO-11-699, a report to congressional requesters Why GAO Did This Study
In 2009, GAO reported on doctor shopping in M... |
Date June 22, 2011 |
Report No. GAO-11-546R |
Title
United States Government Accountability Office Washington, DC 20548 June 22, 2011 The Honorable Henry Waxman Ranking Member Committee on Energy and Commerce House of Representatives The Honorable Frank Pallone Ranking Member Subcommittee on Health Committee on Energy and Commerce House of Representatives The Honorable John D. Dingell House of Representatives Subject: Medicare Part D: Changes in Ut... |
Date Feb. 18, 2011 |
Report No. GAO-11-269R |
Title
United States Government Accountability Office Washington, DC 20548 February 18, 2011 The Honorable Thomas R. Carper Chairman Subcommittee on Federal Financial Management, Government Information, Federal Services, and International Security Committee on Homeland Security and Governmental Affairs United States Senate The Honorable John McCain United States Senate Subject: Medicare Part D: CMS Condu... |
Date Feb. 10, 2011 |
Report No. GAO-11-306R |
Title
United States Government Accountability Office Washington, DC 20548 February 10, 2011 Congressional Requesters Subject: Prescription Drugs: Trends in Usual and Customary Prices for Commonly Used Drugs Prescription drug spending in 2009 totaled approximately $250 billion, of which $78 billion— or about 31 percent—was spent by the federal government. 1 Prescription drug spending by the federal g... |
Date March 17, 2010 |
Report No. GAO-10-529T |
Title
United States Government Accountability Office GAO
For Release on Delivery Expected at 2:30 p.m. EDT Wednesday, March 17, 2010 Testimony Before the Special Committee on Aging, U.S. Senate MEDICARE PART D Spending, Beneficiary Outof-Pocket Costs, and Efforts to Obtain Price Concessions for Certain High-Cost Drugs
Statement of John E. Dicken Director, Health Care GAO-10-529T March 17, 2010 MEDICARE ... |
Date March 3, 2010 |
Report No. GAO-10-481T |
Title
United States Government Accountability Office GAO
For Release on Delivery Expected at 2:30 p.m. EST Wednesday, March 3, 2010 Testimony
Before the Subcommittee on Federal Financial Management, Government Information, Federal Services, and International Security, Homeland Security and Governmental Affairs Committee, U.S. Senate MEDICARE PART D CMS Oversight of Part D Sponsors’ Fraud and Abuse Pro... |
Date Jan. 29, 2010 |
Report No. GAO-10-242 |
Title
United States Government Accountability Office GAO
January 2010 Report to the Chairman, Subcommittee on Health, Committee on Ways and Means, House of Representatives MEDICARE PART D Spending, Beneficiary Cost Sharing, and Cost-Containment Efforts for High-Cost Drugs Eligible for a Specialty Tier GAO-10-242 January 2010 MEDICARE PART D Highlights
Highlights of GAO-10-242, a report to the Chairman, ... |
Date Dec. 28, 2009 |
Report No. GAO-10-185 |
Title
United States Government Accountability Office GAO
December 2009 Report to Congressional Committees MEDICARE MANAGED CARE Observations about Medicare Cost Plans GAO-10-185 December 2009 MEDICARE MANAGED CARE Highlights
Highlights of GAO-10-185, a report to congressional committees Accountability Integrity Reliability Observations about Medicare Cost Plans Why GAO Did This Study
Medicare cost plans... |
Date July 20, 2009 |
Report No. GAO-09-838R |
Title
United States Government Accountability Office Washington, DC 20548 July 20, 2009 The Honorable Thomas R. Carper Chairman The Honorable John McCain Ranking Member Subcommittee on Federal Financial Management, Government Information, Federal Services, and International Security Committee on Homeland Security and Governmental Affairs United States Senate The Honorable Tom Coburn, M.D. United States ... |
Date June 24, 2009 |
Report No. GAO-09-819T |
Title
United States Government Accountability Office GAO
For Release on Delivery Expected at 2:00 p.m. EDT Wednesday, June 24, 2009 Testimony Before the Subcommittee on Federal Workforce, Postal Service, and the District of Columbia, Committee on Oversight and Government Reform, House of Representatives PRESCRIPTION DRUGS Overview of Approaches to Control Prescription Drug Spending in Federal Programs
S... |
Date Dec. 12, 2008 |
Report No. GAO-09-4 |
Title
United States Government Accountability Office GAO
December 2008 Report to the Chairman, Committee on Energy and Commerce, House of Representatives MEDICARE PART D Opportunities Exist for Improving Information Sent to Enrollees and Scheduling the Annual Election Period GAO-09-4 December 2008 MEDICARE PART D Highlights
Highlights of GAO-09-4, a report to the Chairman, Committee on Energy and Commer... |
Date Sept. 30, 2008 |
Report No. GAO-08-1074R |
Title
United States Government Accountability Office Washington, DC 20548 September 30, 2008 The Honorable Henry A. Waxman Chairman Committee on Oversight and Government Reform House of Representatives Subject: Medicare Part D Prescription Drug Coverage: Federal Oversight of Reported Price Concessions Data Dear Mr. Chairman: To help Medicare beneficiaries manage the rising cost of prescription drugs, Co... |
Date Sept. 5, 2008 |
Report No. GAO-08-824 |
Title
United States Government Accountability Office GAO
September 2008 Report to Congressional Committees MEDICARE PART D LOW-INCOME SUBSIDY Assets and Income Are Both Important in Subsidy Denials, and Access to State and Manufacturer Drug Programs Is Uneven GAO-08-824 September 2008 MEDICARE PART D LOW-INCOME SUBSIDY Highlights
Highlights of GAO-08-824, a report to congressional committees Accountabil... |
Date July 21, 2008 |
Report No. GAO-08-760 |
Title
United States Government Accountability Office GAO
July 2008 Report to the Ranking Member, Committee on Finance, U.S. Senate MEDICARE PART D Some Plan Sponsors Have Not Completely Implemented Fraud and Abuse Programs, and CMS Oversight Has Been Limited GAO-08-760 July 2008 MEDICARE PART D Highlights
Highlights of GAO-08-760, a report to the Ranking Member, Committee on Finance, U.S. Senate Account... |
Date June 27, 2008 |
Report No. GAO-08-719 |
Title
United States Government Accountability Office GAO
June 2008 Report to Congressional Requesters MEDICARE PART D Complaint Rates Are Declining, but Operational and Oversight Challenges Remain This report was changed as of 7/1/08 to add Appendix II, which is the agency comment letter that was inadvertently left out of the report. GAO-08-719 June 2008 MEDICARE PART D Highlights
Highlights of GAO-08-7... |
Date May 22, 2008 |
Report No. GAO-08-812T |
Title
United States Government Accountability Office GAO
For Release on Delivery Expected at 10:30 a.m. EDT Thursday, May 22, 2008 Testimony Before the Special Committee on Aging, U.S. Senate MEDICARE PART D LOWINCOME SUBSIDY SSA Continues to Approve Applicants, but Millions of Individuals Have Not Yet Applied
Statement of Barbara D. Bovbjerg, Director Education, Workforce, and Income Security Issues GA... |
Date Jan. 22, 2008 |
Report No. GAO-08-47 |
Title
United States Government Accountability Office GAO
January 2008 Report to Congressional Requesters MEDICARE PART D Plan Sponsors’ Processing and CMS Monitoring of Drug Coverage Requests Could Be Improved GAO-08-47 January 2008 MEDICARE PART D Highlights
Highlights of GAO-08-47, a report to congressional requesters Accountability Integrity Reliability Plan Sponsors’ Processing and CMS Monitorin... |
Date May 31, 2007 |
Report No. GAO-07-555 |
Title
United States Government Accountability Office GAO
May 2007 Report to the Committee on Finance, U.S. Senate MEDICARE PART D LOW-INCOME SUBSIDY Additional Efforts Would Help Social Security Improve Outreach and Measure Program Effects GAO-07-555 May 2007 Highlights
Highlights of GAO-07-555, a report to the Committee on Finance, U.S. Senate Accountability Integrity Reliability MEDICARE PART D LOW-IN... |
Date May 31, 2007 |
Report No. GAO-07-572 |
Title
United States Government Accountability Office GAO
May 2007 Report to Congressional Committees RETIREE HEALTH BENEFITS Majority of Sponsors Continued to Offer Prescription Drug Coverage and Chose the Retiree Drug Subsidy GAO-07-572 May 2007 RETIREE HEALTH BENEFITS Highlights
Highlights of GAO-07-572, a report to congressional committees Accountability Integrity Reliability Majority of Sponsors Con... |
Date May 8, 2007 |
Report No. GAO-07-824T |
Title
United States Government Accountability Office GAO
For Release on Delivery Expected at 10:00 a.m. EDT Tuesday, May 8, 2007 Testimony Before the Committee on Finance, U.S. Senate MEDICARE PART D Enrolling New Dual-Eligible Beneficiaries in Prescription Drug Plans
Statement of Kathleen M. King Director, Health Care GAO-07-824T May 8, 2007 MEDICARE PART D Highlights
Highlights of GAO-07-824T, a testi... |
Date May 8, 2007 |
Report No. GAO-07-858T |
Title
United States Government Accountability Office GAO
For Release on Delivery Expected at 10:00 a.m. EDT Tuesday, May 8, 2007 Testimony before the Senate Committee on Finance MEDICARE PART D LOW-INCOME SUBSIDY Progress Made in Approving Applications, but Ability to Identify Remaining Individuals Is Limited
Statement of Barbara Bovbjerg, Director Education, Workforce, and Income Security Issues GAO-07... |
Date May 4, 2007 |
Report No. GAO-07-272 |
Title
United States Government Accountability Office GAO
May 2007 Report to Congressional Requesters MEDICARE PART D Challenges in Enrolling New Dual-Eligible Beneficiaries GAO-07-272 May 2007 MEDICARE PART D Highlights
Highlights of GAO-07-272, a report to congressional requesters Accountability Integrity Reliability Challenges in Enrolling New Dual-Eligible Beneficiaries Why GAO Did This Study
Since J... |
Date Feb. 9, 2007 |
Report No. GAO-07-481T |
Title
United States Government Accountability Office GAO
For Release on Delivery Expected at 10:00 a.m. EST Friday, February 9, 2007 Testimony Before the Committee on Oversight and Government Reform, House of Representatives PRESCRIPTION DRUGS Oversight of Drug Pricing in Federal Programs
Statement of John E. Dicken Director, Health Care GAO-07-481T February 9, 2007 PRESCRIPTION DRUGS Highlights
Highlig... |
Date Jan. 11, 2007 |
Report No. GAO-07-358T |
Title
United States Government Accountability Office GAO
For Release on Delivery Expected at 10:00 a.m. EST Thursday, January 11, 2007 Testimony Before the Committee on Finance, U.S. Senate PRESCRIPTION DRUGS An Overview of Approaches to Negotiate Drug Prices Used by Other Countries and U.S. Private Payers and Federal Programs
Statement of John E. Dicken Director, Health Care GAO-07-358T January 11, 200... |
Date June 30, 2006 |
Report No. GAO-06-710 |
Title
United States Government Accountability Office GAO
June 2006 Report to Congressional Requesters MEDICARE PART D Prescription Drug Plan Sponsor Call Center Responses Were Prompt, but Not Consistently Accurate and Complete GAO-06-710 June 2006 MEDICARE PART D Highlights
Highlights of GAO-06-710, a report to congressional requesters Accountability Integrity Reliability Prescription Drug Plan Sponsor ... |
Date May 4, 2006 |
Report No. GAO-06-715T |
Title
United States Government Accountability Office GAO
For Release on Delivery Expected at 2:00 p.m. EDT Thursday, May 4, 2006 Testimony Before the Subcommittee on Health, Committee on Ways and Means, House of Representatives MEDICARE Quality of CMS Communications to Beneficiaries on the Prescription Drug Benefit Could Be Improved
Statement of Leslie G. Aronovitz Director, Health Care GAO-06-715T May ... |
Date May 3, 2006 |
Report No. GAO-06-654 |
Title
United States Government Accountability Office GAO
May 2006 Report to Congressional Requesters MEDICARE Communications to Beneficiaries on the Prescription Drug Benefit Could Be Improved GAO-06-654 May 2006 MEDICARE Highlights
Highlights of GAO-06-654, a report to congressional requesters Accountability Integrity Reliability Communications to Beneficiaries on the Prescription Drug Benefit Could Be... |
Date Dec. 16, 2005 |
Report No. GAO-06-278R |
Title
United States Government Accountability Office Washington, DC 20548 December 16, 2005 The Honorable Max Baucus Ranking Minority Member Committee on Finance United States Senate Subject: Medicare: Contingency Plans to Address Potential Problems with the Transition of Dual-Eligible Beneficiaries from Medicaid to Medicare Drug Coverage Dear Senator Baucus: The Medicare Prescription Drug, Improvement,... |
Date Aug. 15, 2005 |
Report No. GAO-05-779 |
Title
United States Government Accountability Office GAO
August 2005 Report to Congressional Requesters PRESCRIPTION DRUGS Price Trends for Frequently Used Brand and Generic Drugs from 2000 through 2004 GAO-05-779 August 2005 PRESCRIPTION DRUGS Highlights
Highlights of GAO-05-779, a report to congressional requesters Accountability Integrity Reliability Price Trends for Frequently Used Brand and Generic... |
Date Feb. 14, 2005 |
Report No. GAO-05-205 |
Title
United States Government Accountability Office GAO
February 2005 Report to Congressional Committees RETIREE HEALTH BENEFITS Options for Employment-Based Prescription Drug Benefits under the Medicare Modernization Act GAO-05-205 February 2005 RETIREE HEALTH BENEFITS Highlights
Highlights of GAO-05-205, a report to congressional committees Accountability Integrity Reliability Options for Employment-... |